Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

which includes our drug-eluting stents and our drug-coated balloon, is now growing close to double digits with drug-eluting stents at now less than 5%. That's less than 5% of our total company ...

This cohort will compare the Medtronic Prevail DCB with Boston Scientific AGENT DCB ... It will compare the Prevail DCB ...

Endoscopy; Urology and Pelvic Health; and Neuromodulation. The company is one of the leading players in the interventional cardiology market with its coronary stent product offerings. Boston ...